Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A
MRVI - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.06B
Close$
$2.12
70.5% downside
Current Fair Value
70.5% downsideOvervalued by 70.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.06 Billion |
|---|---|
| Enterprise Value | $1.02 Billion |
| Earnings per Share | $-0.91 |
| Beta | 0.61 |
| Outstanding Shares | 147,996,000 |
Return
| Return on Equity | -37.82% |
|---|---|
| Return on Assets | -12.82% |
| Return on Invested Capital | -17.37% |
Valuation & Multiples
| P/E Ratio | -14.58 |
|---|---|
| PEG | 21.25 |
| Price to Sales | 7.19 |
| Price to Book Ratio | 3.6 |
| Enterprise Value to Revenue | 4.91 |
| Enterprise Value to EBIT | -10.43 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$-0.05
Consensus analyst estimateRevenue Estimate
$48.67 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-0.06
Consensus analyst estimateRevenue Estimate
$43.56 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 35.75% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.20%▼ 95.30% |
|---|---|
| Total Invested | $2.31M▼ 99.74% |
| Investors Holding | 15▼ 172.00% |
About Maravai LifeSciences Holdings Inc
3 employees
Maravai LifeSciences enables the development of drug therapies, diagnostics and novel vaccines and supports research on human diseases through its portfolio of market-leading companies and proprietary technologies. Maravai companies are ...